menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

TB Reactivation & Immune-Mediated Inflammatory Diseases

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • In Collaboration with

  • Overview

    It’s critical that we understand whether or not a patient with an immune-mediated inflammatory disease has latent tuberculosis (TB) before starting treatment with inhibitory therapies as this can impact TB reactivation frequencies and the risk of complications. Dr. Jeffrey Cirillo from the Texas A&M College of Medicine explains how we can test for latent TB.

Facebook Comments

Recommended
Details
Presenters
Comments
  • In Collaboration with

  • Overview

    It’s critical that we understand whether or not a patient with an immune-mediated inflammatory disease has latent tuberculosis (TB) before starting treatment with inhibitory therapies as this can impact TB reactivation frequencies and the risk of complications. Dr. Jeffrey Cirillo from the Texas A&M College of Medicine explains how we can test for latent TB.

Facebook Comments

Schedule22 Oct 2021
Webpack App